Prof Gerald Fogarty is Director of Radiation Oncology at The Mater Hospital, Sydney. He trained at Peter MacCallum Cancer Centre. He is also a radiation oncologist with GenesisCare and the Melanoma Institute of Australia. He authored the radiotherapy section of the 2019 NHMRC Management of Keratinocyte Guidelines. He is a former board member of the Melanoma and Skin Cancer Trials Group and former Chair of the Australian Merkel Interest Group.

Professor Fogarty’s goal is to establish level one evidence for radiation in skin disease. He is an active researcher having over 150 publications and he has a H index of 25.